Premium
Schwann cells express IP prostanoid receptors coupled to an elevation in intracellular cyclic AMP
Author(s) -
Muja Naser,
Nelson Julie K.,
DeVries George H.
Publication year - 2007
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.21221
Subject(s) - prostanoid , forskolin , endocrinology , prostaglandin e2 receptor , stimulation , medicine , creb , receptor , purinergic receptor , microbiology and biotechnology , biology , prostaglandin , chemistry , adenosine , biochemistry , agonist , transcription factor , gene
Abstract We have shown previously that prostaglandin E 2 (PGE 2 ) and prostaglandin I 2 (PGI 2 ) are each produced in an explant model of peripheral nerve injury. We report that IP prostanoid receptor mRNA and protein are present in primary rat Schwann cells. IP prostanoid receptor stimulation using prostacyclin produced an elevation in intracellular cyclic AMP concentration ([cAMP] i ) in primary Schwann cells. Peak [cAMP] i was observed between 5–15 min of stimulation followed by a gradual recovery toward basal level. Phosphorylation of cyclic AMP‐response element binding protein (CREB) on Ser 133 was also detected after IP prostanoid receptor stimulation and CREB phosphorylation was inhibited completely by the protein kinase A inhibitor, H‐89. Intracellular calcium levels were not affected by IP prostanoid receptor stimulation. Unlike forskolin, IP prostanoid receptor stimulation did not significantly augment Schwann cell proliferation in response to growth factor treatment. However, IP prostanoid receptor stimulation increased the number of Schwann cells that were able to generate a calcium transient in response to P2 purinergic receptor activation. These findings suggest that signaling via the IP prostanoid receptor may by relevant to Schwann cell biology in vivo. © 2007 Wiley‐Liss, Inc.